Literature DB >> 25173986

Determination of Δ9-tetrahydrocannabinolic acid A (Δ9-THCA-A) in whole blood and plasma by LC-MS/MS and application in authentic samples from drivers suspected of driving under the influence of cannabis.

Nikolaos Raikos1, Helene Schmid2, Susanne Nussbaumer2, Lars Ambach2, Stephan Lanz2, Andreas Längin2, Stefan König2, Nadine Roth3, Volker Auwärter3, Wolfgang Weinmann4.   

Abstract

Delta-9-tetrahydrocannabinolic acid A (THCA-A) is the biosynthetic precursor of delta-9-tetrahydrocannabinol (THC) in cannabis plants, and has no psychotropic effects. THCA-A can be detected in blood and urine, and several metabolites have been identified. THCA-A was also shown to be incorporated in hair by side stream smoke to a minor extent, but incorporation via blood stream or sweat seems unlikely. The detection of THCA-A in biological fluids may serve as a marker for differentiating between the intake of prescribed THC medication - containing only pure THC - and cannabis products containing THC besides THC-acid A and other cannabinoids. However, the knowledge about its usefulness in forensic cases is very limited. The aim of the present work was the development of a reliable method for THCA-A determination in human blood or plasma using LC-MS/MS and application to cases of driving under the influence of drugs. Fifty eight (58) authentic whole blood and the respective plasma samples were collected from drivers suspected of driving under the influence of cannabis from the region of Bern (Switzerland). Samples were first tested for THC, 11-OH-THC and THC-COOH, and then additionally for THCA-A. For this purpose, the existing LC-MS/MS method was modified and validated, and found to be selective and linear over a range of 1.0 to 200ng/mL (the correlation coefficients were above 0.9980 in all validation runs). Limit of detection (LOD) and limit of quantification (LOQ) were 0.3ng/mL and 1.0ng/mL respectively. Intra- and inter-assay accuracy were equal or better than 90% and intra- and inter-assay precision were equal or better than 11.1%. The mean extraction efficiencies were satisfactory being equal or higher than 85.4%. THCA-A was stable in whole blood samples after 3 freeze/thaw cycles and storage at 4°C for 7 days. Re-injection (autosampler) stability was also satisfactory. THC was present in all blood samples with levels ranging from 0.7 to 51ng/mL. THCA-A concentrations ranged from 1.0 to 496ng/mL in blood samples and from 1.4 to 824ng/mL in plasma samples. The plasma:blood partition coefficient had a mean value of 1.7 (±0.21, SD). No correlation was found between the degree of intoxication or impairment stated in the police protocols or reports of medical examinations and the detected THCA-A-concentration in blood.
Copyright © 2014 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Keywords:  Delta-9-tetrahydrocannabinolic acid A; Impairment; LC–MS/MS; Plasma; Whole blood

Mesh:

Substances:

Year:  2014        PMID: 25173986     DOI: 10.1016/j.forsciint.2014.07.026

Source DB:  PubMed          Journal:  Forensic Sci Int        ISSN: 0379-0738            Impact factor:   2.395


  8 in total

1.  Quantification of cannabinoids and their free and glucuronide metabolites in whole blood by disposable pipette extraction and liquid chromatography-tandem mass spectrometry.

Authors:  Karl B Scheidweiler; Matthew N Newmeyer; Allan J Barnes; Marilyn A Huestis
Journal:  J Chromatogr A       Date:  2016-05-07       Impact factor: 4.759

Review 2.  Acidic Cannabinoid Decarboxylation.

Authors:  Crist N Filer
Journal:  Cannabis Cannabinoid Res       Date:  2021-09-22

3.  Tetrahydrocannabinolic acid is a potent PPARγ agonist with neuroprotective activity.

Authors:  Xavier Nadal; Carmen Del Río; Salvatore Casano; Belén Palomares; Carlos Ferreiro-Vera; Carmen Navarrete; Carolina Sánchez-Carnerero; Irene Cantarero; Maria Luz Bellido; Stefan Meyer; Gaetano Morello; Giovanni Appendino; Eduardo Muñoz
Journal:  Br J Pharmacol       Date:  2017-11-02       Impact factor: 8.739

4.  Simultaneous quantification of 11 cannabinoids and metabolites in human urine by liquid chromatography tandem mass spectrometry using WAX-S tips.

Authors:  Maria Andersson; Karl B Scheidweiler; Cristina Sempio; Allan J Barnes; Marilyn A Huestis
Journal:  Anal Bioanal Chem       Date:  2016-07-15       Impact factor: 4.142

5.  Self-Reported Cannabis Use and Markers of Inflammation in Men Who Have Sex With Men With and Without HIV.

Authors:  Martin Krsak; Nikolas I Wada; Michael W Plankey; Gregory L Kinney; Marta Epeldegui; Chukwuemeka N Okafor; Mackey Reuel Friedman; Frank J Palella; Kristine M Erlandson
Journal:  Cannabis Cannabinoid Res       Date:  2021-04-15

Review 6.  The biosynthesis of the cannabinoids.

Authors:  M Nazir Tahir; Fred Shahbazi; Simon Rondeau-Gagné; John F Trant
Journal:  J Cannabis Res       Date:  2021-03-15

7.  Identification of Potential Distinguishing Markers for the Use of Cannabis-Based Medicines or Street Cannabis in Serum Samples.

Authors:  Anne Scheunemann; Katrin Elsner; Tanja Germerott; Sergiu Groppa; Cornelius Hess; Isabelle Miederer; Alicia Poplawski; Jörg Röhrich
Journal:  Metabolites       Date:  2021-05-13

Review 8.  Can You Pass the Acid Test? Critical Review and Novel Therapeutic Perspectives of Δ9-Tetrahydrocannabinolic Acid A.

Authors:  Guillermo Moreno-Sanz
Journal:  Cannabis Cannabinoid Res       Date:  2016-06-01
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.